Newsfile Corp
15 Oct 2026, 18:45 UTC · 2h ago
Kaplan Fox Encourages Hims & Hers Health, Inc. (HIMS) Investors to Learn About the Securities Class Action Ahead of the November 2, 2026 Deadline
Impact · against what's priced in
The news is largely a non-event for HIMS as the market has already baked in the regulatory fallout from the FTC lawsuit. The announcement of a corresponding securities class action is a standard secondary consequence that reinforces the existing legal drag the stock is currently pricing.
- HIMS−0.05
Already priced in
- The price assumes
Significant legal and regulatory friction, including FTC lawsuits over data privacy and billing practices.





